Hepatitis e virus (HEV) strains in serum samples can replicate efficiently in cultured cells despite the coexistence of HEV antibodies: Characterization of HEV virions in blood circulation

Journal of Clinical Microbiology

Volumn 48, Issue 4, 2010, Pages 1112-1125

  Takahashi, Masaharu ^a   Tanaka, Toshinori ^a   Takahashi, Hideyuki ^a   Hoshino, Yu ^a   Nagashima, Shigeo ^a   Jirintai, ^a   Mizuo, Hitoshi ^b   Yazaki, Yasuyuki ^c   Takagi, Tomofumi ^d   Azuma, Masahiro ^a   Kusano, Eiji ^a   Isoda, Norio ^a   Sugano, Kentaro ^a   Okamoto, Hiroaki ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b Kin ikyo Chuo Hospital   (Japan)

^c Kobayashi Hospital   (Japan)

^d Sapporo Shakai Hoken General Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS E ANTIBODY; ORF3 PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CIRCULATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENOTYPE; HEPATITIS E VIRUS; HUMAN; IMMUNOPRECIPITATION; IN VITRO STUDY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SUCROSE DENSITY GRADIENT CENTRIFUGATION; VIRION; VIRUS LOAD; VIRUS PARTICLE; VIRUS REPLICATION;

CELL CULTURE TECHNIQUES; CELL LINE; CENTRIFUGATION, DENSITY GRADIENT; HEPATITIS ANTIBODIES; HEPATITIS E VIRUS; HUMANS; MOLECULAR SEQUENCE DATA; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; SERUM; VIROLOGY;

HEPATITIS E VIRUS;

EID: 77950495043     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.02002-09     Document Type: Article

References (66)

1. Arankalle, V. A., and L. P. Chobe. 2000. Retrospective analysis of blood transfusion recipients: evidence for post-transfusion hepatitis E. Vox Sang. 79:72-74.
2. Boxall, E., A. Herborn, G. Kochethu, G. Pratt, D. Adams, S. Ijaz, and C. G. Teo. 2006. Transfusion-transmitted hepatitis E in a 'nonhyperendemic' country. Transfus. Med. 16:79-83.
3. 3. Chandra, V., A. Kar-Roy, S. Kumari, S. Mayor, and S. Jameel. 2008. The hepatitis E virus ORF3 protein modulates epidermal growth factor receptor trafficking, STAT3 translocation, and the acute-phase response. J. Virol. 82:7100-7110. (Pubitemid 351977728)
4. Chandra, V., S. Taneja, M. Kalia, and S. Jameel. 2008. Molecular biology and pathogenesis of hepatitis E virus. J. Biosci. 33:451-464.
5. Dalton, H. R., R. Bendall, S. Ijaz, and M. Banks. 2008. Hepatitis E: an emerging infection in developed countries. Lancet Infect. Dis. 8:698-709.
6. Emerson, S. U., D. Anderson, A. Arankalle, X. J. Meng, M. Purdy, G. G. Schlauder, and S. A. Tsarev. 2004. Hepevirus, p. 853-855. In C. M. Fauquet, M. A. Mayo, J. Maniloff, U. Desselberger, and L. A. Ball (ed.), Virus taxonomy: VIIIth report of the ICTV. Elsevier/Academic Press, London, United Kingdom.
7. Emerson, S. U., and R. H. Purcell. 2006. Hepatitis E virus, p. 3047-3058. In D. M. Knipe, P. M. Howley, D. E. Griffin, R. A. Lamb, M. A. Martin, B. Roizman, and S. E. Straus (ed.), Fields virology, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
8. Emerson, S. U., P. Clemente-Casares, N. Moiduddin, V. A. Arankalle, U. Torian, and R. H. Purcell. 2006. Putative neutralization epitopes and broad cross-genotype neutralization of hepatitis E virus confirmed by a quantitative cell-culture assay. J. Gen. Virol. 87:697-704.
9. Felsenstein, J. 1985. Confidence limits on phylogenies: an approach using the bootstrap. Evolution 39:783-791.
10. Graff, J., H. Nguyen, C. Yu, W. R. Elkins, M. St. Claire, R. H. Purcell, and S. U. Emerson. 2005. The open reading frame 3 gene of hepatitis E virus contains a cis-reactive element and encodes a protein required for infection of macaques. J. Virol. 79:6680-6689.
11. 11. Graff, J., U. Torian, H. Nguyen, and S. U. Emerson. 2006. A bicistronic subgenomic mRNA encodes both the ORF2 and ORF3 proteins of hepatitis E virus. J. Virol. 80:5919-5926. (Pubitemid 43849169)
12. Guu, T. S., Z. Liu, Q. Ye, D. A. Mata, K. Li, C. Yin, J. Zhang, and Y. J. Tao. 2009. Structure of the hepatitis E virus-like particle suggests mechanisms for virus assembly and receptor binding. Proc. Natl. Acad. Sci. USA 106:12992-12997.
13. Harrison, T. J. 1999. Hepatitis E virus - an update. Liver 19:171-176.
14. He, S., J. Miao, Z. Zheng, T. Wu, M. Xie, M. Tang, J. Zhang, M. H. Ng, and N. Xia. 2008. Putative receptor-binding sites of hepatitis E virus. J. Gen. Virol. 89:245-249.
15. Holinger, F. B., and S. U. Emerson. 2006. Hepatitis A virus, p. 911-947. In D. M. Knipe, P. M. Howley, D. E. Griffin, R. A. Lamb, M. A. Martin, B. Roizman, and S. E. Straus (ed.), Fields virology, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
16. Huang, Y. W., T. Opriessnig, P. G. Halbur, and X. J. Meng. 2007. Initiation at the third in-frame AUG codon of open reading frame 3 of the hepatitis E virus is essential for viral infectivity in vivo. J. Virol. 81:3018-3026.
17. Ina, Y. 1994. ODEN: a program package for molecular evolutionary analysis and database search of DNA and amino acid sequences. Comput. Appl. Biosci. 10:11-12.
18. Khuroo, M. S., S. Kamili, and G. N. Yattoo. 2004. Hepatitis E virus infection may be transmitted through blood transfusions in an endemic area. J. Gastroenterol. Hepatol. 19:778-784.
19. Lemon, S. M., L. N. Binn, and R. H. Marchwicki. 1983. Radioimmunofocus assay for quantitation of hepatitis A virus in cell cultures. J. Clin. Microbiol. 17:834-839.
20. Lemon, S. M., and L. N. Binn. 1985. Incomplete neutralization of hepatitis A virus in vitro due to lipid-associated virions. J. Gen. Virol. 66:2501-2505.
21. Li, S., X. Tang, J. Seetharaman, C. Yang, Y. Gu, J. Zhang, H. Du, J. W. Shih, C. L. Hew, J. Sivaraman, and N. Xia. 2009. Dimerization of hepatitis E virus capsid protein E2s domain is essential for virus-host interaction. PLoS Pathog. 5:e1000537.
22. Lorenzo, F. R., T. Tanaka, H. Takahashi, K. Ichiyama, Y. Hoshino, K. Yamada, J. Inoue, M. Takahashi, and H. Okamoto. 2008. Mutational events during the primary propagation and consecutive passages of hepatitis E virus strain JE03-1760F in cell culture. Virus Res. 137:86-96.
23. Lu, L., C. Li, and C. H. Hagedorn. 2006. Phylogenetic analysis of global hepatitis E virus sequences: genetic diversity, subtypes and zoonosis. Rev. Med. Virol. 16:5-36.
24. 24. Matsubayashi, K., Y. Nagaoka, H. Sakata, S. Sato, K. Fukai, T. Kato, K. Takahashi, S. Mishiro, M. Imai, N. Takeda, and H. Ikeda. 2004. Transfusiontransmitted hepatitis E caused by apparently indigenous hepatitis E virus strain in Hokkaido, Japan. Transfusion 44:934-940. (Pubitemid 38738426)
25. Matsubayashi, K., J. H. Kang, H. Sakata, K. Takahashi, M. Shindo, M. Kato, S. Sato, T. Kato, H. Nishimori, K. Tsuji, H. Maguchi, J. Yoshida, H. Maekubo, S. Mishiro, and H. Ikeda. 2008. A case of transfusion-transmitted hepatitis E caused by blood from a donor infected with hepatitis E virus via zoonotic food-borne route. Transfusion 48:1368-1375.
26. 26. Meng, J., X. Dai, J. C. Chang, E. Lopareva, J. Pillot, H. A. Fields, and Y. E. Khudyakov. 2001. Identification and characterization of the neutralization epitope(s) of the hepatitis E virus. Virology 288:203-211. (Pubitemid 32929900)
27. Meng, X. J. 2005. Hepatitis E as a zoonotic disease, p. 611-623. In H. C. Thomas, S. Lemon, and A. J. Zuckerman (ed.), Viral hepatitis, 3rd ed. Blackwell Publishing, Malden, MA.
28. Mitsui, T., Y. Tsukamoto, C. Yamazaki, K. Masuko, F. Tsuda, M. Takahashi, T. Nishizawa, and H. Okamoto. 2004. Prevalence of hepatitis E virus infection among hemodialysis patients in Japan: evidence for infection with a genotype 3 HEV by blood transfusion. J. Med. Virol. 74:563-572.
29. Mizuo, H., K. Suzuki, Y. Takikawa, Y. Sugai, H. Tokita, Y. Akahane, K. Itoh, Y. Gotanda, M. Takahashi, T. Nishizawa, and H. Okamoto. 2002. Polyphyletic strains of hepatitis E virus are responsible for sporadic cases of acute hepatitis in Japan. J. Clin. Microbiol. 40:3209-3218.
30. 30. Nomura, M., M. Imai, F. Tsuda, S. Furuta, Y. Akahane, K. Tachibana, S. Usuda, Y. Miyakawa, and M. Mayumi. 1985. Immunoglobulin A antibody against hepatitis B core antigen in the acute and persistent infection with hepatitis B virus. Gastroenterology 89:1109-1113. (Pubitemid 16231578)
31. Okamoto, H., M. Takahashi, and T. Nishizawa. 2003. Features of hepatitis E virus infection in Japan. Intern. Med. 42:1065-1071.
32. 32. Okamoto, H. 2007. Genetic variability and evolution of hepatitis E virus. Virus Res. 127:216-228. (Pubitemid 47058196)
33. Panda, S. K., D. Thakral, and S. Rehman. 2007. Hepatitis E virus. Rev. Med. Virol. 17:151-180.
34. Provost, P. J., B. S. Wolanski, W. J. Miller, O. L. Ittensohn, W. J. McAleer, and M. R. Hilleman. 1975. Physical, chemical and morphologic dimensions of human hepatitis A virus strain CR326 (38578). Proc. Soc. Exp. Biol. Med. 148:532-539.
35. Purcell, R. H., S. M. Feinstone, J. R. Ticehurst, R. J. Daemer, and B. M. Baroudy. 1984. Hepatitis A virus, p. 9-22. In G. N. Vyas, J. L. Dienstag, and J. H. Hoofnagle (ed.), Viral hepatitis and liver disease. Grune & Stratton, Orlando, FL.
36. Purcell, R. H., and S. U. Emerson. 2008. Hepatitis E: an emerging awareness of an old disease. J. Hepatol. 48:494-503.
37. Rueckert, R. 1976. On the structure and morphogenesis of picornaviruses, p. 131-213. In H. Frankel-Conrat and R. R. Wagner (ed.), Comprehensive virology, vol.6. Plenum Press, New York, NY.
38. Saitou, N., and M. Nei. 1987. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol. Biol. Evol. 4:406-425.
39. Schlauder, G. G., and I. K. Mushahwar. 2001. Genetic heterogeneity of hepatitis E virus. J. Med. Virol. 65:282-292.
40. 40. Schofield, D. J., J. Glamann, S. U. Emerson, and R. H. Purcell. 2000. Identification by phage display and characterization of two neutralizing chimpanzee monoclonal antibodies to the hepatitis E virus capsid protein. J. Virol. 74:5548-5555. (Pubitemid 30346588)
41. Schofield, D. J., R. H. Purcell, H. T. Nguyen, and S. U. Emerson. 2003. Monoclonal antibodies that neutralize HEV recognize an antigenic site at the carboxyterminus of an ORF2 protein vaccine. Vaccine 22:257-267.
42. Shrestha, M. P., R. M. Scott, D. M. Joshi, M. P. Mammen, Jr., G. B. Thapa, N. Thapa, K. S. Myint, M. Fourneau, R. A. Kuschner, S. K. Shrestha, M. P. David, J. Seriwatana, D. W. Vaughn, A. Safary, T. P. Endy, and B. L. Innis. 2007. Safety and efficacy of a recombinant hepatitis E vaccine. N. Engl. J. Med. 356:895-903.
43. Smith, J. L. 2001. A review of hepatitis E virus. J. Food Prot. 64:572-586.
44. Suzuki, K., T. Aikawa, and H. Okamoto. 2002. Fulminant hepatitis E in Japan. N. Engl. J. Med. 347:1456.
45. Takahashi, T., S. Nakagawa, T. Hashimoto, K. Takahashi, M. Imai, Y. Miyakawa, and M. Mayumi. 1976. Large-scale isolation of Dane particles from plasma containing hepatitis B antigen and demonstration of a circular double-stranded DNA molecule extruding directly from their cores. J. Immunol. 117:1392-1397.
46. 46. Takahashi, K., A. Machida, G. Funatsu, M. Nomura, S. Usuda, S. Aoyagi, K. Tachibana, H. Miyamoto, M. Imai, T. Nakamura, Y. Miyakawa, and M. Mayumi. 1983. Immunochemical structure of hepatitis B e antigen in the serum. J. Immunol. 130:2903-2907. (Pubitemid 13107729)
47. Takahashi, M., T. Nishizawa, H. Miyajima, Y. Gotanda, T. Iita, F. Tsuda, and H. Okamoto. 2003. Swine hepatitis E virus strains in Japan form four phylogenetic clusters comparable with those of Japanese isolates of human hepatitis E virus. J. Gen. Virol. 84:851-862.
48. 48. Takahashi, K., N. Kitajima, N. Abe, and S. Mishiro. 2004. Complete or near-complete nucleotide sequences of hepatitis E virus genome recovered from a wild boar, a deer, and four patients who ate the deer. Virology 330:501-505. (Pubitemid 39572856)
49. Takahashi, M., S. Kusakai, H. Mizuo, K. Suzuki, K. Fujimura, K. Masuko, Y. Sugai, T. Aikawa, T. Nishizawa, and H. Okamoto. 2005. Simultaneous detection of immunoglobulin A (IgA) and IgM antibodies against hepatitis E virus (HEV) is highly specific for diagnosis of acute HEV infection. J. Clin. Microbiol. 43:49-56.
50. Takahashi, M., T. Tanaka, M. Azuma, E. Kusano, T. Aikawa, T. Shibayama, Y. Yazaki, H. Mizuo, J. Inoue, and H. Okamoto. 2007. Prolonged fecal shedding of hepatitis E virus (HEV) during sporadic acute hepatitis E: evaluation of infectivity of HEV in fecal specimens in a cell culture system. J. Clin. Microbiol. 45:3671-3679.
51. Takahashi, M., Y. Hoshino, T. Tanaka, H. Takahashi, T. Nishizawa, and H. Okamoto. 2008. Production of monoclonal antibodies against hepatitis E virus capsid protein and evaluation of their neutralizing activity in a cell culture system. Arch. Virol. 153:657-666.
52. Takahashi, M., K. Yamada, Y. Hoshino, H. Takahashi, K. Ichiyama, T. Tanaka, and H. Okamoto. 2008. Monoclonal antibodies raised against the ORF3 protein of hepatitis E virus (HEV) can capture HEV particles in culture supernatant and serum but not those in feces. Arch. Virol. 153:1703-1713.
53. Tam, A. W., M. M. Smith, M. E. Guerra, C. Huang, D. W. Bradley, K. E. Fry, and G. R. Reyes. 1991. Hepatitis E virus (HEV): molecular cloning and sequence of the full-length viral genome. Virology 185:120-130.
54. Tamura, A., Y. K. Shimizu, T. Tanaka, K. Kuroda, Y. Arakawa, K. Takahashi, S. Mishiro, K. Shimizu, and M. Moriyama. 2007. Persistent infection of hepatitis E virus transmitted by blood transfusion in a patient with T-cell lymphoma. Hepatol. Res. 37:113-120.
55. Tanaka, T., M. Takahashi, E. Kusano, and H. Okamoto. 2007. Development and evaluation of an efficient cell-culture system for Hepatitis E virus. J. Gen. Virol. 88:903-911.
56. Tanaka, T., M. Takahashi, H. Takahashi, K. Ichiyama, Y. Hoshino, S. Nagashima, H. Mizuo, and H. Okamoto. 2009. Development and characterization of a genotype 4 hepatitis E virus cell culture system using a HE-JF5/15F strain recovered from a fulminant hepatitis patient. J. Clin. Microbiol. 47:1906-1910.
57. 57. Tei, S., N. Kitajima, K. Takahashi, and S. Mishiro. 2003. Zoonotic transmission of hepatitis E virus from deer to human beings. Lancet 362:371-373. (Pubitemid 36945060)
58. 58. Tsuda, F., S. Naito, E. Takai, Y. Akahane, S. Furuta, Y. Miyakawa, and M. Mayumi. 1984. Low molecular weight (7s) immunoglobulin M antibody against hepatitis B core antigen in the serum for differentiating acute from persistent hepatitis B virus infection. Gastroenterology 87:159-164. (Pubitemid 14122766)
59. Tyagi, S., H. Korkaya, M. Zafrullah, S. Jameel, and S. K. Lal. 2002. The phosphorylated form of the ORF3 protein of hepatitis E virus interacts with its non-glycosylated form of the major capsid protein, ORF2. J. Biol. Chem. 277:22759-22767.
60. Tyagi, S., M. Surjit, A. K. Roy, S. Jameel, and S. K. Lal. 2004. The ORF3 protein of hepatitis E virus interacts with liver-specific alpha1-microglobulin and its precursor alpha1-microglobulin/bikunin precursor (AMBP) and expedites their export from the hepatocyte. J. Biol. Chem. 279:29308-29319.
61. Williams, T. P., C. Kasorndorkbua, P. G. Halbur, G. Haqshenas, D. K. Guenette, T. E. Toth, and X. J. Meng. 2001. Evidence of extrahepatic sites of replication of the hepatitis E virus in a swine model. J. Clin. Microbiol. 39:3040-3046.
62. Wilson, I. G. 1997. Inhibition and facilitation of nucleic acid amplification. Appl. Environ. Microbiol. 63:3741-3751.
63. Yamada, K., M. Takahashi, Y. Hoshino, H. Takahashi, K. Ichiyama, S. Nagashima, T. Tanaka, and H. Okamoto. 2009. ORF3 protein of hepatitis E virus is essential for virion release from infected cells. J. Gen. Virol. 90:1880-1891.
64. Yamashita, T., Y. Mori, N. Miyazaki, R. H. Cheng, M. Yoshimura, H. Unno, R. Shima, K. Moriishi, T. Tsukihara, T. C. Li, N. Takeda, T. Miyamura, and Y. Matsuura. 2009. Biological and immunological characteristics of hepatitis E virus-like particles based on the crystal structure. Proc. Natl. Acad. Sci. USA 106:12986-12991.
65. Yazaki, Y., H. Mizuo, M. Takahashi, T. Nishizawa, N. Sasaki, Y. Gotanda, and H. Okamoto. 2003. Sporadic acute or fulminant hepatitis E in Hokkaido, Japan, may be food-borne, as suggested by the presence of hepatitis E virus in pig liver as food. J. Gen. Virol. 84:2351-2357.
66. Zhao, C., Z. Ma, T. J. Harrison, R. Feng, C. Zhang, Z. Qiao, J. Fan, H. Ma, M. Li, A. Song, and Y. Wang. 2009. A novel genotype of hepatitis E virus prevalent among farmed rabbits in China. J. Med. Virol. 81:1371-1379.